In 1978, if anyone had been told that within 40 years Maoist-oriented China would be rapidly gaining on the United States as having the largest economy in the world, you would have been labelled delusional, if not totally…
China’s Zhixiang – A Global Pharmaceutical Industry

June 19, 2017 | Category: Blog | Tags: China CMO, China pharmaceutical industry, Fill and Finish, PaizaBio, Zhixiang
China’s Regulatory Mosaic: The Troops Have Their Marching Orders

China’s State Council has announced to its people and to the world that the second largest drug market will become a world leader in pharmaceutical innovation, commercialization and manufacturing. Simply put, China will no longer rely on research-based…
April 30, 2017 | Category: Blog | Tags: China CMO, China Drug Industry, China Fill Finish, David Deere PaizaBio, PaizaBio
China’s Drug Industry Reforms: Is the Mosaic Finally Coming Together for Western Pharma?

A note from author David Deere: To foster a global and innovative pharmaceutical industry and reduce the disproportional healthcare costs attributable to drugs, the Chinese government has formally targeted the industry for economic development. To facilitate these objectives,…
April 24, 2017 | Category: Blog | Tags: China CMO, China Consulting, China CRO, China Drug Industry, China Fill and Finish, PaizaBio
Chinese Drug Reform and the Knights Templar: Symbolism or Coincidence?

A David Deere Advisory Alert Nine centuries ago, wealthy Christians often made pilgrimages from Europe to Jerusalem, among the most sacred places in the Holy Land. It was, to say the least, an arduous and dangerous journey. In…
March 17, 2017 | Category: Blog | Tags: China CMO, China Drug Industry, China Fill/Finish, David Deere, New CFDA Policy, PaizaBio
The Year of the Fire Rooster Sets the Stage for China-US Relations

“Always higher, always going on.” – Motto of the Chinese Zodiac’s Rooster It seems appropriate that China’s 2017 New Year is the year of the Red Fire Rooster. The tenth Chinese zodiac sign, the Rooster is known for…
January 24, 2017 | Category: Blog | Tags: Alibaba, China CMO, Davos, Fill and Finish, Jack Ma, PaizaBio, President Trump, President Xi Jinping, Switzerland, Trans-Pacific Partnership, World Economic Forum
Update on CFDA’s Fast-Track Approval: 7 MNC Products Move to Data Inspection Stage

It’s been a little more than a year since China’s FDA (CFDA) announced sweeping policy changes intended to streamline the review of innovative new drugs and rid their system of subpar applicants blocking the progress of true candidates…
January 10, 2017 | Category: Blog | Tags: CFDA Policy Changes, China CMO, China Fill Finish, Fast Track Approval
PaizaBio’s Message for J.P. Morgan Week? China Is Open for Business

ALBUQUERQUE, New Mexico (January 5, 2017) – As thousands of life sciences executives and investors descend on San Francisco for the 35th Annual J.P. Morgan Healthcare Conference next week, PaizaBio has a simple message: China, the world’s second…
January 4, 2017 | Category: Press Releases | Tags: China CMO, PaizaBio, Sterile Injectable Drugs China
China’s Pharmaceutical “Sea Turtles” – Innovation or Imitation and Does It Matter?

During a discussion about the future direction of immuno-oncology pharmaceuticals at the Annual ChinaBio® Partnering Meeting held in Suzhou, China, last May, one point of disagreement among the panelists was whether the number of Chinese companies targeting development…
December 13, 2016 | Category: Blog | Tags: China CMO, China Fill Finish, Chinese CMO, PaizaBio, Sea Turtles
PaizaBio’s Deere to Reveal Global Pharma’s Salvation at CPhI Pharma Insights
“China is in the midst of regulatory ‘shock and awe.’ PaizaBio provides multinational pharmaceutical companies with much needed on-the-ground insight and a clear path forward in China.” October 4, 2016 I 2:30 PM I Pharma Forum Theater 1,…
August 23, 2016 | Category: Blog | Tags: China CMO, PaizaBio Deere